跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NIFIBRO SOFT CAPSULES 150 mg - HSA Drug Approval Details
Approvals
/
HSA
/
NIFIBRO SOFT CAPSULES 150 mg
Approved
THERAPEUTIC
NIFIBRO SOFT CAPSULES 150 mg
Lotus Pharmaceutical Co., Ltd. (TAIWAN)
🇸🇬 Health Sciences Authority
Approval Date
Aug 4, 2026
Approval ID
0d9486822f1c0e1c
Company
Lotus Pharmaceutical Co., Ltd. (TAIWAN)
Type
Therapeutic
Approval Details
Approval Id
0d9486822f1c0e1c
Drug Name
NIFIBRO SOFT CAPSULES 150 mg
Product Name
NIFIBRO SOFT CAPSULES 150 mg
Approval Number
SIN17605P
Approval Date
2026-08-04
Registrant
LOTUS INTERNATIONAL PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
CAPSULE, LIQUID FILLED
Route Of Administration
ORAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Aug 4, 2026
Approval ID
0d9486822f1c0e1c
Type
Therapeutic
Back to HSA Approvals